Reading GEHC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track GEHC free→Reading GEHC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track GEHC free→QuarterlyIQ Insights · GEHC
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On April 29, 2026 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its first quarter 2026 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the “Company”) appointed Kevin A. Lobo to serve as a director of the Company, effective immediately. Mr. Lobo’s term will expire at the Company’s 2026 Annual Meeting of Stockholders. The Board also appointed Mr. Lobo as a member of the Talent, Culture, and C…
Termination of a Material Definitive Agreement. In connection with the Company’s entry into the New Revolving Credit Agreement, the 2025 364-Day Revolving Credit Agreement, which provided for a $0.5 billion 364-day senior unsecured revolving credit facility, was terminated without penalty on February 26, 2026.
Entry into a Material Definitive Agreement. On February 26, 2026, GE HealthCare Technologies Inc. (the “Company”) entered into a 364-Day Revolving Credit Agreement (the “New Revolving Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5 billion. The New Revolving Credit Facility replaces the 364-Day Revolving Credi…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information provided in
Results of Operations and Financial Condition. On February 4, 2026 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its fourth quarter 2025 and fiscal year ended December 31, 2025 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as…
Entry into a Material Definitive Agreement. On December 12, 2025, GE HealthCare Technologies Inc. (the “Company”) entered into a three-year senior unsecured term loan credit facility (the “Term Loan Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein. Pursuant to the Term Loan Credit Agreement, the lenders thereunder have committed to make an unsecured term loan in an aggregate amount of $750 million (the “Term Loan”), which…
Other Events. On December 15, 2025, the Company issued $600,000,000 aggregate principal amount of 4.150% Senior Notes due December 15, 2028 (the “2028 Notes”) and $650,000,000 aggregate principal amount of 4.950% Senior Notes due December 15, 2035 (the “2035 Notes” and, together with the 2028 Notes, the “Notes”) pursuant to its effective shelf registration statement on Form S-3 (File No. 333-280584). The Company intends to use the net proceeds from the offering of the Notes, together with the…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information provided in
Results of Operations and Financial Condition. On October 29, 2025 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its third quarter 2025 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwis…
Results of Operations and Financial Condition. On July 30, 2025 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its second quarter 2025 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 23, 2025, Lloyd W. Howell, Jr. notified GE HealthCare Technologies Inc. (the “Company”) of his resignation from the Company’s Board of Directors (the “Board”), effective immediately. Mr. Howell’s resignation from the Board was not a result of any disagreement on a matter related to the Company’s operations, policies, or practices. SIGNATURE…
Other Events. On June 9, 2025, GE HealthCare Technologies Inc. (the “Company”) issued $650,000,000 aggregate principal amount of 4.800% Senior Notes due January 15, 2031 (the “2031 Notes”) and $850,000,000 aggregate principal amount of 5.500% Senior Notes due June 15, 2035 (the “2035 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to its effective shelf registration statement on Form S-3 (File No. 333-280584). Interest on the 2031 Notes will be payable on January 15 and July 1…
Other Events. On April 30, 2025, the Board of Directors of GE HealthCare authorized a share repurchase program (the “program”) pursuant to which GE HealthCare may repurchase up to $1.0 billion of its common stock. The program does not have an expiration date.
Results of Operations and Financial Condition. On April 30, 2025 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its first quarter 2025 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information provided in
Entry into a Material Definitive Agreement. On March 27, 2025, GE HealthCare Technologies Inc. (the “Company”) entered into (i) a 364-Day Revolving Credit Agreement (the “2025 364-Day Revolving Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5 billion, and (ii) a Credit Agreement (the “2025 Credit Agreement”) am…
Termination of a Material Definitive Agreement. In connection with the Company’s entry into the New Credit Agreements, the 2024 364-Day Revolving Credit Agreement, which provided for a $1.0 billion 364-day senior unsecured revolving credit facility, and the 2022 Credit Agreement, which provided for a $2.5 billion senior unsecured revolving credit facility, were each terminated without penalty on March 27, 2025.
Results of Operations and Financial Condition. On February 13, 2025 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its fourth quarter and fiscal year ended December 31, 2024 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amen…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information provided in
Entry into a Material Definitive Agreement. On December 11, 2024, GE HealthCare Technologies Inc. (the “Company”) entered into a 364-Day Revolving Credit Agreement (the “2024 364-Day Revolving Credit Agreement”) among the Company, Citibank, N.A., as administrative agent, and the lenders named therein (the “Lenders”), which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $1.0 billion. The 2024 364-Day Revolving Credit Facility replaces the…
Results of Operations and Financial Condition. On October 30, 2024 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its third quarter 2024 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwis…
Results of Operations and Financial Condition. On July 31, 2024 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its second quarter 2024 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise…
Results of Operations and Financial Condition. On April 30, 2024 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its first quarter 2024 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 9, 2024, Jan Makela, Chief Executive Officer, Imaging, notified GE HealthCare Technologies Inc. (the “Company”) that he will be resigning from his role at the Company to become the chief executive officer of a private company that is not one of the Company’s competitors. The Company will evaluate internal and external candidates to fill th…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.